EML
Home
Recent Updates
Favourites
Search
Directory
Guidelines
Medicines
Tools
About
Feedback
Disclaimer
Directory
Guidelines
Search
Medicines
Tools
Antineoplastic and Immunomodulating Agents
Basiliximab
ATC Code
Indication
NEMLC Recommendation
Review Indicators
Date Ratified
ATC CODE
L04AC02
INDICATION
Induction therapy in low risk patient's renal transplantation recipients.
NEMLC RECOMMENDATION
Approved
REVIEW INDICATORS
None
DATE RATIFIED
29 June 2017